Clinical Trials for Cutaneous T Cell Lymphoma

Find clinical trials for cutaneous t cell lymphoma. Discover research opportunities and treatment options in your area.

21 Active Trials Found

Showing 21 trials on this page

Page 1 of 2

Real World Experience With Mogamulizumab in the Treatment of Cutaneous T-cell Lymphoma

NCT ID: NCT06113081

This clinical trial is studying the effectiveness and safety of a treatment called mogamulizumab for patients with cutaneous T-cell lymphoma (CTCL), a type of skin cancer. The goal is to understand...

Recruiting

Type: observational Locations: Ancona, , Italy, Avellino, , Italy +19 more

A Clinical Trial in Adults With Non-Hodgkin Lymphoma (NHL), With a Particular Emphasis on Cutaneous T Cell Lymphoma (CTCL), Testing the Safety and Activity of a Novel Drug to Inhibit a Protein Called Tumor Necrosis Factor Receptor 2 That Drives Both Lymphoma Growth and Escape of the Immune System

NCT ID: NCT06385522

This clinical trial is studying a new drug called BITR2101 to see if it can help treat a type of cancer known as non-Hodgkin lymphoma (NHL), particularly focusing on patients with cutaneous T cell ...

Not yet recruiting

Phase: PHASE1 Type: interventional

Confirmatory Study of Topical HyBryte™ vs. Placebo for the Treatment of CTCL

NCT ID: NCT06470451

This clinical trial is studying a treatment called HyBryte, which is a special cream used to help patients with a type of skin cancer known as cutaneous T-cell lymphoma (CTCL), specifically during ...

Recruiting

Phase: PHASE3 Type: interventional Locations: Chicago, Illinois, United States, Philadelphia, Pennsylvania, United States +15 more

Ropeginterferon in Patients w/Cutaneous T-Cell Lymphoma (CTCL)

NCT ID: NCT07047885

This clinical trial is studying a medication called Ropeginterferon-alfa 2b (P1101) to see how well it works and what dose is best for people with a type of skin cancer called Cutaneous T-Cell Lymp...

Recruiting

Phase: PHASE1 Type: interventional Locations: Tampa, Florida, United States

Combating Cancer-Related Fatigue: A Personalized Supportive Care Program

NCT ID: NCT06860880

This clinical trial, titled "Combating Cancer-Related Fatigue: A Personalized Supportive Care Program," is designed to help patients with certain types of indolent lymphomas, including chronic lymp...

Recruiting

Phase: NA Type: interventional Locations: Chapel Hill, North Carolina, United States

Systemic Therapies in the Treatment of Cutaneous T-cell Lymphoma

NCT ID: NCT06588868

This clinical trial is looking into different ways to treat Cutaneous T-cell Lymphoma (CTCL), which is a type of skin cancer. The goal is to understand how systemic therapies (treatments that affec...

Recruiting

Type: observational Locations: Firenze, , Italy, Milano, , Italy +16 more

Pembrolizumab and Mogamulizumab in Advanced-stage, Relapsed/Refractory Cutaneous T-cell Lymphomas

NCT ID: NCT05956041

This clinical trial is looking at the effectiveness of two medications, pembrolizumab and mogamulizumab, in treating patients with advanced-stage cutaneous T-cell lymphoma (CTCL) that has come back...

Recruiting

Phase: PHASE2 Type: interventional Locations: Ann Arbor, Michigan, United States

Study of CAR-T Cells Expressing CD30 and CCR4 for r/r CD30+ HL and CTCL

NCT ID: NCT03602157

This clinical trial is studying a new type of treatment for certain types of lymphoma, which is a cancer of the immune system. The treatment involves using specially modified T cells (a type of whi...

Recruiting

Phase: PHASE1 Type: interventional Locations: Chapel Hill, North Carolina, United States

Treatment of Mycosis Fungoides with Hypericin Ointment and Visible Light

NCT ID: NCT05872854

This clinical trial is investigating a new treatment for a type of skin cancer called mycosis fungoides, which is a form of cutaneous T-cell lymphoma. The treatment involves using a special ointmen...

Recruiting

Phase: PHASE2 Type: interventional Locations: Philadelphia, Pennsylvania, United States

JAK1 Inhibitor Golidocitnib for the Treatment of Relapsed/refractory Indolent T/NK-cell Lymphomas

NCT ID: NCT06716658

This clinical trial is studying a new treatment called Golidocitnib for patients with indolent T/NK-cell lymphomas, which are types of blood cancers that grow slowly but are currently hard to cure....

Recruiting

Phase: PHASE2 Type: interventional Locations: Tianjin, , China, Tianjin, Tianjin, China

Pilot Study to Characterize the Microbiome in Cutaneous T Cell Lymphoma Skin Lesions Before and After Use of CLn® Skin Care Body Wash

NCT ID: NCT06665490

This clinical trial aims to study how a special body wash called CLn® (which contains a very diluted solution of sodium hypochlorite) affects the skin of patients with a type of skin cancer called ...

Not yet recruiting

Type: observational Locations: Chicago, Illinois, United States

Evaluation of the KIR3DL2 Marker in Flow Cytometry for Sézary Syndrome Diagnosis, Therapeutic Response and Residual Disease: a Prospective and Multicenter Study

NCT ID: NCT06651203

This clinical trial is looking at a specific marker called KIR3DL2 to help improve the diagnosis and treatment of Sézary syndrome, a type of skin cancer that affects T-cells. The study aims to see ...

Not yet recruiting

Type: observational

A Pilot of a Microdevice For In Situ Candidate Drug Screening in Cutaneous Lesions of T-Cell Lymphoma

NCT ID: NCT04045470

This clinical trial is exploring a new way to treat cutaneous T-cell lymphoma and peripheral T-cell lymphoma, which are types of skin cancers. Researchers want to see if a small device that can rel...

Recruiting

Phase: NA Type: interventional Locations: Boston, Massachusetts, United States

Mogamulizumab and Brentuximab Vedotin in CTCL and Mycosis Fungoides

NCT ID: NCT05414500

This clinical trial is studying the safety and effectiveness of two medications, Mogamulizumab and Brentuximab Vedotin, for treating specific types of skin lymphomas called Cutaneous T Cell Lymphom...

Recruiting

Phase: PHASE1 Type: interventional Locations: Birmingham, Alabama, United States

Post-authorization Safety Study of Allogeneic Hematopoietic Stem Cell Transplantation in Patients Treated With Mogamulizumab

NCT ID: NCT04014374

This clinical trial is studying the safety of a treatment called mogamulizumab in patients with certain types of blood cancers, specifically cutaneous T-cell lymphoma (CTCL) and adult T-cell leukem...

Recruiting

Type: observational Locations: Milwaukee, Wisconsin, United States

Photopheresis in Early-stage Mycosis Fungoides

NCT ID: NCT05680558

This clinical trial is studying a treatment called photopheresis for patients with early-stage cutaneous T-cell lymphoma, specifically a type known as Mycosis Fungoides. Photopheresis is currently ...

Recruiting

Phase: PHASE2 Type: interventional Locations: New York, New York, United States

A Study of Molecular Subtyping-based Therapeutic Strategies for Cutaneous T-cell Lymphoma

NCT ID: NCT06436677

This clinical trial is studying a new way to treat cutaneous T-cell lymphoma (CTCL), a type of cancer that affects the skin. The researchers want to find out if using specific tests to understand t...

Recruiting

Type: observational Locations: Beijing, Beijing, China, Beijing, Beijing, China +3 more

Characterization of the Microbiome in Cutaneous T Cell Lymphoma Skin Lesions Before and After Use of APR-TD011® (RLF-TD011®) Spray Solution

NCT ID: NCT05728879

This clinical trial is investigating the effects of a special spray called APR-TD011 on skin lesions caused by a type of cancer known as Cutaneous T Cell Lymphoma (CTCL). The study aims to understa...

Not yet recruiting

Phase: EARLY_PHASE1 Type: interventional Locations: Chicago, Illinois, United States

Characterization of the Microbiome in Cutaneous T Cell Lymphoma

NCT ID: NCT03932279

This clinical trial is studying the microbiome in patients with cutaneous T cell lymphoma, which is a type of cancer that affects the skin. The researchers want to understand how the bacteria and o...

Recruiting

Type: observational Locations: Chicago, Illinois, United States

A Phase I Trial of SIM1811-03 in Subjects With Advanced Tumors

NCT ID: NCT05781386

This clinical trial is testing a new medication called SIM1811-03, which aims to treat patients with advanced tumors, including a type of skin cancer known as Cutaneous T Cell Lymphoma (CTCL). This...

Recruiting

Phase: PHASE1 Type: interventional Locations: Guanzhou, Guangdong, China

Related Conditions

Breast Cancer View clinical trials → Stroke View clinical trials → Obesity View clinical trials → Cancer View clinical trials → Healthy View clinical trials → Prostate Cancer View clinical trials →

Search All Trials Browse All Conditions